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In studies on the relation between indoor mold exposure and symptoms/disease, the exposure
should be described in terms of biomass and not viability. This paper reviews field studies in
which (1--3)-P-D-glucan was measured as a marker of biomass and was related to the extent of
symptoms and measures of inflammation among exposed subjects. Increased levels of (1->3)-n-
D-glucan were related to an increased extent of symptoms and markers of inflammation. The data
suggest that (1--3)-1-D-glucan can be used as a risk marker in indoor environments. Key words:
airways inflammation, (1--3)-P3-D-glucan, indoor air, molds. - Environ Health Perspect 107(suppl
3):501-503 (1999).
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Background
Effects related to indoor air have been
reported in a large number ofstudies from
different countries (1,2). The major symp-
toms are irritation in the eyes, nose and
throat; dry cough; fatigue/headache; and
skin problems, all ofwhich can be caused
by nonspecific airway inflammation (3).
Many studies show a relationship
between symptoms and a history ofdamp-
ness or flooding ofbuildings (4). Humidity
in building structures favors the growth of
fungi and certain bacteria. These micro-
organisms contain several agents with impor-
tant biologic properties, such as endotoxin,
mycotoxins, (1 ->3)-P-D-glucan, and differ-
ent allergens that can cause a variety oftoxi-
cologic and immunologic effects (5).
Although the development ofan infection
requires that the organism be viable, these
effects do not require viability. Risk estima-
tions based on viability are thus not relevant,
and indicators ofcell biomass or measures of
thespecific toxic agentshouldbe used.
Several agents in microbes have been
used to determine biomass. Endotoxin is
widely used for the estimation of Gram-
negative bacteria (6). Ergosterol has been
used to determine fungal biomass (7).
(1--3)-P-D-glucan, a polyglucose com-
pound present in the cell wall offungi, cer-
tain bacteria and vegetable materials, has
also been used (8).
A number of studies have used meas-
urements of airborne (1--3)-f3-D-glucan
to estimate mold exposure and to evaluate
the relation with effects present in the
exposed populations. A review of these
studies is presented in the following
sections, preceded by a description of the
analytical methods for determination of
(143)-P1-D-glucan.
Measurement of
(1->3)-P-D-Glucan
(1-3)-j-D-Glucan is a polyglucose com-
pound in which the biologic activity is
caused by the unique (1->3)-P-bindings
between the polyglucose rings. From an
analytical point ofview, a chemical analysis
is thus very difficult, and the techniques
available rely on biologic reactions.
One commonly used method was
developed in Japan for the purpose of fol-
lowing the clinical progress ofdeep mycosis
(9). The method is based on the reactivity
of the amebocyte present in the Limulus
horseshoe crab to react specifically with the
(1-*3)-P-D-glucan molecule. The method
is extremely sensitive and quantities can be
detected as small as a few picrograms.
In our laboratory, samples of air are
taken by drawing air through Isopore filters
(ATTP 0.8 pm, Millipore, Cambridge,
MA) at a flow rate of 5 L/min for 30 min.
The filters are shaken for 10 min in 10 mL
of pyrogen-free water. Thereafter 0.3 M
NaOH is added, and the filters are shaken
on ice for 10 min to unwind the triple helix
structure of the glucan and make it water
soluble. Filter extract samples of 50 pL are
placed in a microwell plate, and 50 mL spe-
cific glucan lysate (Fungitic G Test,
Seikagaku Co., Tokyo, Japan) is added.
The plate is incubated in a spectropho-
tometer (Wellreader, Scinics Corp., Tokyo,
Japan), and the kinetics of the ensuing
color reaction are read photometrically,
transformed into absorbance units, and
compared to a standard curve. The results
are expressed as nanograms per milliliter of
liquid. Using the value for airflow through
the filter, this value is transformed to
nanograms per cubic meter. The detection
limit for the technique is 20 pg/mL. As the
method is very sensitive, even the slightest
contamination with molds ofthe equipment
or the laboratory space will introduce errors
in the results, and control filter and solution
always need to be analyzed in parallel.
Another method is based on a highly
specific inhibition enzyme immunoassay
(EIA), developed for the quantitation of
(1->3)-P-D-glucan in dust samples from
the occupational and residential environ-
ment (10). Immunospecific rabbit anti-
bodies are produced by immunization with
bovine serum albumin-conjugated lami-
narin [a (1-*3)-IB-D-glucan] and affinity
chromatography. The laminarin-based cali-
bration curve in the inhibition EIA ranges
from approximately 40-3,000 ng/mL
(15-85% inhibition). Another (1->3)-P-D-
glucan, curdlan, shows a similar inhibition
curve but is 3 to 5 times less reactive on a
weight basis. Other polysaccharides such as
,B(1->6)-glucan and mannan do not react
in the inhibition EIA. The assay can detect
heat-extractable (1-3)-P-D-glucan in dust
samples collected in a variety of occupa-
tional and environmental settings such as
compost facilities, swine confinement
buildings, and homes. Both fungal and
plant (1-*3)-P-D-glucans are detectable in
the assay. Based on duplicate analyses of
dust samples, the coefficient ofvariation is
approximately 25%.
In the studies described in this paper,
the air samples were taken using aggressive
sampling. We used a device stirring up the
air from the floor using an air stream,
which is passed over the surface of the
room in which the sampling is performed.
Without this procedure, the dust (and
mold) particles will rapidly set on the floor
surface and air sampling would give a false
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negative value in environments where
there is no or little movement of persons.
Alternatives are to sample over a pro-
longed period, e.g., 8 hr during periods of
normal movement in the room or to use a
personal sampler.
Studies Performed
The first published study reported an inves-
tigation ofa number offlats in a small town
in Sweden (11). The presence ofsymptoms
was evaluated using questionnaires, and
measurements of (1-*3)-P-D-glucan were
made in the houses. The exposure was
divided into three classes-high, medium,
and low glucan. The proportion ofpersons
reporting symptoms indicative of airways
inflammation was related to the amount
of glucan measured indoors. A similar
relationship was found for fatigue.
The second study involved a number of
buildings where complaints had been made
about indoor air-related symptoms-a day-
care center, a post office, and two primary
schools (12). An office building where no
symptoms had been reported served as a
control. All persons working full time in the
buildings received a questionnaire originally
developed to assess the effects oforganic
dusts and modified for indoor conditions.
Questions were asked about symptoms in
the eyes and airways as well as fatigue and
headache. Ofthe 442 subjects selected for
the study, 437 participated. A total of39
persons in the buildings with symptoms and
405 persons in the control building was
investigated. Measurements were made of
the amount of airborne endotoxin and
(1-+3)-P-D-glucan. The results are summa-
rized in Table 1. It is seen that the extent of
different symptoms was related to levels of
airborne (1->3)-[B-D-glucan.
A case study in Switzerland comprised a
clinical investigation oftwo boys living in a
house with indoor mold growth and
Table 1. Airborne levels of (1->3)-P-D-glucan in rela-
tion to extent of symptoms.a
Day-care/
Control post office School 1/2
n 405 19 20
Glucan (ng/m3)b <0.1 1.3 5.2
% with symptoms
Nasal irritation 16 37 50
Throat irritation 11 37 45
Dry cough 6 5 35
Headache 2 5 30
Fatigue 21 58 75
'Summarized by Rylander et al. (12). bAdjusted according to
later modification ofthe Limulus assay.
airborne (1-*3)-P-D-glucan levels ranging
between 5 and 106 ng/m3 (mean 41.9)
(13). The boys developed severe airway
inflammation with cough, wheezing, and
fatigue after about 6 months ofliving in the
house; one boy became sensitized to house
dust mites.
The symptoms disappeared when the
boys moved out ofthe house. About a year
later, the parents developed airway inflam-
mation and they were also forced to move
from the house. A similar case history was
reported in Sweden (14). In this study,
three children reported intense symptoms of
airway inflammation and fatigue/headache.
Two of the children were on medication
with bronchodilators. Levels of(W1-3)-P-D-
glucan ranged from 21.8 to 115.2 ng/m3 in
different rooms ofthe house. The children
finally moved to their grandmother's house,
and the symptoms cleared within a few
months. These case studies demonstrate that
children living in home environments with
molds may develop severe airway symptoms
as well as fatigue and headache. Except for
the sensitization to mites in one child, no
evidence ofallergic reactions was present.
The rapid improvement in both cases
when the children moved out of their
homes supports a hypothesis ofcausality.
One study was performed in a day-care
center with a history of dampness (15).
For several years, symptoms of nasal
swelling, throat irritation, headache, and
fatigue had been reported by the staff. The
15 staff members were investigated by
questionnaire, and a methacholine test was
performed to determine airway responsive-
ness. A few months later, the center was
closed for renovation and the personnel
worked elsewhere. After the renovation,
they returned to the center and were
examined 1 and 2 years later.
The amount ofairborne (1->3)-P-D-
glucan before the renovation was 11.4
ng/m3 (n= 24, SD = 2.3) and 1.3 ng/m3 (n
= 13, SD = 0.9, p < 0.0001) after the reno-
vation. The results ofmeasurements ofair-
way responsiveness (Table 2) showed that
there was a tendency for the average
Table 2. Airway responsiveness before and after
building renovation. Change of FEV1 after inhalation of
1.2 mg methacholine.ab
Before 2 years 3 years
n 11 11 11
FEV1 1%) -7.8(6.2) -4.0(6.6) -5.9(8.8)
n>4% 8 2 3
FEV1, forced expiratory volume. 'Figures in parentheses are
standard deviations and numbers of persons with a decrease
largerthan 4%. bSummarized from Rylander etal. (12).
decrease in forcedexpiratoryvolume (FEV1)
after methacholine challenge to be lower at
2 and 3 years after the renovation compared
to before. The number of persons with
decreases in FEV, larger than 4% was lower
at 2 and 3 years (p = 0.03 and 0.08, x2,
Yate's correction). Two ofthe staffreported
that they had developed an allergy (to cats)
at the reexamination at 2 years.
A recent study was performed in an
area with rowhouses, some ofwhich had
problems with dampness and mold growth
(16). The study comprised 75 houses with
indoor air (1-*3)-P-D-glucan levels rang-
ing from 0 to 19 ng/m3. The tenants were
invited to a clinical examination and 127
persons participated. The amount of
myeloperoxidase in blood was higher
among those living in houses with levels of
(1- >3)-P-D-glucan > 1 ng/m3 (p = 0.03).
This group also showed a significant inverse
relationship between the baseline FEV, and
the number ofyears the person lived in the
house, when controlling for age, gender,
smoking, asthma, atopy, and house pets.
The proportion ofatopic persons was higher
among those living in houses where levels of
(1-*3)-5-D-glucan exceeded 4 ng/m3 (24.6
vs 13.2%), although the difference was not
statistically significant.
A follow-up study was made with
volunteers from the rowhouse study (17).
A blood sample was taken and blood
monocytes were isolated for determina-
tion of cytokine production before and
after in vitro cell stimulation. After com-
paring persons with an increased level of
(1->3)-P-D-glucan in their homes with
those in homes with low or undetectable
levels, an increased baseline production of
tumor necrosis factor a was found.
Several studies have investigated the
children's environments. In an inves-
tigation in Sweden, two schools-one
with mold problems and another without
problems-were studied (18). The extent
of respiratory symptoms was significantly
higher in the school with higher levels of
(1->3)-P-D-glucan (15.3 ng/m3) than in
the school with low levels (2.9 ng/m3).
Among atopic children, the extent ofsymp-
toms ofdry cough, cough with phlegm, and
hoarseness was similar to those of the
nonatopics in the low (1-*3)-fP-D-glucan
school but significantly more common in
the high(1--3)-P-D-glucan school.
Comments
A general conclusion from the studies
reviewed here is that there was a relation
between exposure to (1->3)-P-D-glucan as
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an indicator of mold biomass and the
extent ofsymptoms ofairway inflamma-
tion, fatigue, and headache. Some data
show that objective measurements of
inflammation were also related to the expo-
sure. In some ofthe studies, dose-response
relationships could be demonstrated. For
field measurements, (1-*3)-P-D-glucan
may thus be a suitable indicator ofrisk.
Even if there is a relation between
indoor air effects and the amount of
(1->3)-fB-D-glucan, this cannot be taken as
evidence for a causal relationship. (1-*3)-n-
D-glucan is an indicator offungal biomass,
but fungi contain a variety ofagents with
biologic effects. Support for causalitywould
require exposures to isolated (1->3)-P-D-
glucan, preferably using atopic and asth-
matic subjects. Although a few such studies
have been reported and have confirmed an
effect on the airways (19), there is still a
great need for further research in that area.
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